CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use by Boeuf, Philippe et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
BMC Immunology
Open Access Methodology article
CyProQuant-PCR: a real time RT-PCR technique for profiling 
human cytokines, based on external RNA standards, readily 
automatable for clinical use
Philippe Boeuf1, Inès Vigan-Womas1, Delphine Jublot1, Séverine Loizon1, 
Jean-Christophe Barale2, Bartholomew Dicky Akanmori3, Odile Mercereau-
Puijalon1 and Charlotte Behr*1
Address: 1Unité d'Immunologie Moléculaire des Parasites, URA CNRS 2581, Département de Parasitologie et de Médecine Moléculaire, Institut 
Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France, 2Unité d'Immunophysiopathologie Infectieuse, URA CNRS 1961, Département 
d'Immunologie, Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France and 3Immunology Unit, Noguchi Memorial Institute for 
Medical Research, PO box LG 581, Legon, Ghana
Email: Philippe Boeuf - pboeuf@pasteur.fr; Inès Vigan-Womas - ivigan@pasteur.fr; Delphine Jublot - djublot@pasteur.fr; 
Séverine Loizon - sloizon@pasteur.fr; Jean-Christophe Barale - jcb@pasteur.fr; 
Bartholomew Dicky Akanmori - Bakanmori@noguchi.mimcom.net; Odile Mercereau-Puijalon - omp@pasteur.fr; 
Charlotte Behr* - charlotte.behr@pasteur.fr
* Corresponding author    
Abstract
Background: Real-time PCR is becoming a common tool for detecting and quantifying expression profiling of selected
genes. Cytokines mRNA quantification is widely used in immunological research to dissect the early steps of immune
responses or pathophysiological pathways. It is also growing to be of clinical relevancy to immuno-monitoring and
evaluation of the disease status of patients. The techniques currently used for "absolute quantification" of cytokine mRNA
are based on a DNA standard curve and do not take into account the critical impact of RT efficiency.
Results: To overcome this pitfall, we designed a strategy using external RNA as standard in the RT-PCR. Use of synthetic
RNA standards, by comparison with the corresponding DNA standard, showed significant variations in the yield of retro-
transcription depending the target amplified and the experiment. We then developed primers to be used under one single
experimental condition for the specific amplification of human IL-1β , IL-4, IL-10, IL-12p40, IL-13, IL-15, IL-18, IFN-γ , MIF,
TGF-β 1 and TNF-α  mRNA. We showed that the beta-2 microglobulin (β 2-MG) gene was suitable for data normalisation
since the level of β 2-MG transcripts in naïve PBMC varied less than 5 times between individuals and was not affected by
LPS or PHA stimulation. The technique, we named CyProQuant-PCR (Cytokine Profiling Quantitative PCR) was
validated using a kinetic measurement of cytokine transcripts under in vitro stimulation of human PBMC by
lipopolysaccharide (LPS) or Staphylococcus aureus strain Cowan (SAC). Results obtained show that CyProQuant-PCR is
powerful enough to precociously detect slight cytokine induction. Finally, having demonstrated the reproducibility of the
method, it was applied to malaria patients and asymptomatic controls for the quantification of TGF-β 1 transcripts and
showed an increased capacity of cells from malaria patients to accumulate TGF-β 1 mRNA in response to LPS.
Conclusion: The real-time RT-PCR technique based on a RNA standard curve, CyProQuant-PCR, outlined here, allows
for a genuine absolute quantification and a simultaneous analysis of a large panel of human cytokine mRNA. It represents
a potent and attractive tool for immunomonitoring, lending itself readily to automation and with a high throughput. This
opens the possibility of an easy and reliable cytokine profiling for clinical applications.
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Background
Cytokines are a family of low-molecular weight proteins
secreted by various cell types, with pleiotropic functions
and constitute a tightly regulated network that plays a cen-
tral role in the immune system. Cytokines, classified into
different groups such as interleukins (IL), interferons
(IFN), colony-stimulating factors (CSF), tumour necrosis
factors (TNF), tumour growth factors (TGF) and chemok-
ines are implicated in the differentiation, proliferation,
migration and effector functions of immune cells. Inter-
acting one with the others, they have polarizing effects on
the target cells and are pivotal in tuning immune
responses [1]. Therefore, it is rather the make-up of
cytokines milieu that influences the immune response
rather than the action of a single cytokine. Numerous
studies indicate that the clinical and/or immunological
status depends on the balance between pro-inflammatory
cytokines and their regulatory counterparts [2]. Thus,
cytokine profiling should be achieved through analysis of
simultaneous quantification of a pattern of cytokines
including pro and anti-inflammatory cytokines [2,3].
Moreover, recent reports have highlighted the need for
clinical immuno-monitoring of patients to adapt treat-
ment or prevent relapses [4-6]. Thus, analysis of the
cytokine pattern is central not only in the definition of the
immunological status of patients but also in the study of
the pathophysiological pathways as well as the cellular
subpopulations involved [7,8].
Cytokines are often produced locally so that the concen-
tration of circulating cytokines in the plasma is usually
low. Their half-life and turnover may vary complicating
the delineation of informative cytokine profiles. Although
transcription of messenger RNA is not strictly correlated to
protein secretion and activity, detection of cytokine RNA
by real time PCR is now considered a reference technique
for analysis of small-size samples with high sensitivity [9].
It can be used on its own or to validate and complement
information obtained with other techniques such as
micro-arrays [10,11].
The already available techniques, which offer a so-called
"absolute quantification" of the target cytokine mRNA,
achieve quantification by reference to an external stand-
ard curve based on serial dilutions of a known amount of
the corresponding cDNA [12]. Moreover, to allow for
comparison between experiments, data are normalized by
reference to an internal standard, which is an endogenous
gene for which the number of copy per cell is supposed
constant under different experimental conditions [13,14].
The term of "absolute" quantification is not completely
appropriate since these techniques neither control for the
variable efficiency of the RT step nor take it into account
in their measurements [15,16].
In the present study, we first show that the efficiency of
the RT step depends on the target mRNA and on the exper-
iments and that these variations have critical impact on
the reliability of mRNA quantification. To overcome this,
we describe here CyProQuant-PCR, a new technique for
absolute measurement of cytokine mRNA based on an
external RNA standard curve. Primer pairs have been
designed for allowing amplification of a set of cytokine
mRNA using the same conditions both in terms of ther-
mocycling parameters and master mix components, a pre-
requisite for multiple cytokine mRNA measurements with
high throughput.
In the present paper, we describe i) the construction of the
synthetic RNA standard, ii) the primer pairs specific for
the following human cytokines IL-1β , IL-4, IL-10, IL-
12p40, IL-13, IL-15, IL-18, IFN-γ , and for the tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activa-
tion protein, zeta polypeptide (YWHAZ), the β 2-
microglobulin (β 2-MG) and the ubiquitin-C (UBC) to be
used as internal standards and iii) the conditions for effi-
cient real time amplification of multiple cytokine specific
mRNA. The technique was validated using in vitro stimu-
lated PBMC and its intra and inter-experimental variabil-
ity were assessed. Finally, CyProQuant-PCR was used to
quantify TGF-β 1 transcripts in small blood samples from
children with acute Plasmodium falciparum malaria.
Results
Primer design and validation
Primer pairs were designed from published genomic
sequences using Primer Express software (Applied Biosys-
tems), except for the UBC and the YWHAZ genes for
which the primers had already been described [17]. When
possible, the following criteria were applied. The percent
of G+C content was kept in the 20–80% range and runs of
an identical nucleotide were avoided. The five nucleotides
at the 3' end had no more than two G and/or C bases and
the melting temperature was kept between 58 and 60°C.
Among the primers proposed by Primer Express software,
we selected forward and reverse primers amplifying a
product spanning one intron and not leading to the
amplification of pseudogenes or other related genes to
secure primer specificity for target cDNA. The specificity of
the amplification was assessed for each gene by electro-
phoresis and dissociation curve analysis as shown in Fig-
ure 1A and 1B. The absence of any contaminating bands
corresponding to genomic DNA amplification on agarose
gel as well as the presence of a unique peak on the disso-
ciation curve validated the specificity of the primer pair
for the target cDNA. PCR products were systematically
sequenced after cloning and showed more than 98% iden-
tity with the expected sequence (data not shown).BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
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Primer validation Figure 1
Primer validation. A. Agarose gel electrophoresis of several CyProQuant-PCR products generated by amplification of a 
pool of cDNA from PBMC stimulated in vitro by LPS or PHA. Scale is shown in base pairs (bp). B. Dissociation curve analysis of 
these CyProQuant-PCR products. Negative derivative of the fluorescence is plotted against temperature. The single peak 
shows that SYBR Green fluorescence detects only the specific CyProQuant-PCR product. C. Amplification plots and standard 
curve resulting from the amplification of a range of β 2-MG external RNA standard using CyProQuant-PCR.
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Primer concentrations were optimised to determine the
minimum primer concentrations giving the lowest thresh-
old cycle (CT) and the maximum signal-to-noise fluores-
cence ratio (∆ Rn) while minimising non-specific
amplification (data not shown). Among the final concen-
trations of 50, 300 and 900 nM tested for each primer, the
optimal final concentration was set at 900 nM for every
primer. The primer pairs are shown in Table I.
Standard curve design
Generation of the RNA standard curve
To generate the standard RNA corresponding to each tar-
get sequence, gene specific primers were fused in their 5'
end to the RNA polymerase T7 promoter sequence. The
PCR performed with these modified primers pairs lead to
a larger PCR product with the T7 promoter sequences
upstream and downstream from the specific amplicon.
The in vitro transcription gave a synthetic RNA, which was
assessed for its integrity and clonality by electrophoresis
(data not shown). The molecular mass of each RNA stand-
ard was calculated on the basis of its sequence and solu-
tions ranging from 101 to 1012 copies of standard RNA
were made.
These serial diluted solutions were reverse transcribed and
the cDNA amplified in duplicate to generate a standard
curve by plotting the threshold cycle (CT) against the
logarithmic value of the starting RNA copy number for
each dilution. Figure 1C shows an example of these curves
for β 2-MG. Every curve generated a dynamic range of a
least 6 orders of magnitude. This allowed for a reliable
and reproducible quantification of cellular mRNA
sample.
Comparison between CyProQuant-PCR and DNA standard based 
approach
CyProQuant-PCR was compared to the classical approach
based on a DNA standard curve for the quantification of
TNF-α , IL-1β  and IFN-γ  transcripts. DNA templates for
RNA transcription of TNF-α , IL-1β  and IFN-γ  were used to
Table 1: Primer sequences used for Cyproquant assays Table shows position of amplification product within cDNA sequence (upper 
line) and within genomic sequence (lower line). GenBank accession numbers are indicated.
Gene name 5'-3' primer sequence Position cDNA-gene Accesion Number
IL-1β FW CCTGTCCTGCGTGTTGAAAGA 639–788 NM_000576
RW GGGAACTGGGCAGACTCAAA Int. Span. M15840
IL-4 FW AACAGCCTCACAGAGCAGAAGAC 177–278 BC070123
RW GCCCTGCAGAAGGTTTCCTT Int. Span. AF395008
IL-10 FW GCTGGAGGACTTTAAGGGTTACCT 210–318 AY029171
RW CTTGATGTCTGGGTCTTGGTTCT Int. Span. AF418271
IL-12p40 FW CATGGTGGATGCCGTTCA 636–767 AF180563
RW ACCTCCACCTGCCGAGAAT Int. Span. AY008847
IL-13 FW ACAGCCCTCAGGGAGCTCAT 135–231 NM_002188
RW TCAGGTTGATGCTCCATACCAT Int. Span. AF377331
IL-15 FW CCATCCAGTGCTACTTGTGTTTACTT 351–466 U14407
RW CCAGTTGGCTTCTGTTTTAGGAA Int. Span. X91233
IL-18 FW GACGCATGCCCTCAATCC 966–1071 NM_001562
RW CTAGAGCGCAATGGTGCAATC Exon E17138
IFN-γ FW GTTTTGGGTTCTCTTGGCTGTTA 151–263 NM_000619
RW AAAAGAGTTCCATTATCCGCTACATC Int. Span. AF375790
MIF FW GCCCGGACAGGGTCTACA 322–399 M25639
RW CTTAGGCGAAGGTGGAGTTGTT Int. Span. L19686
TGF-β 1 FW CAAGGGCTACCATGCCAACT 1786–1869 NM_000660
RW AGGGCCAGGACCTTGCTG Int. Span. X05839
TNF-α FW CCCCAGGGACCTCTCTCTAATC 358–455 NM_000594
RW GGTTTGCTACAACATGGGCTACA Int. Span. AB088112
β 2-MG FW AATTGAAAAAGTGGAGCATTCAGA 255–389 NM_004048
RW GGCTGTGACAAAGTCACATGGTT Exon M17987
UBC FW ATTTGGGTCGCGGTTCTTG 20–152 BC039193
RW TGCCTTGACATTCTCGATGGT Int. Span. D63791
YWHAZ FW ACTTTTGGTACATTGTGGCTTCAA 1090–1183 NM_003406
RW CCGCCAGGACAAACCAGTAT Exon NC_000008
Note: FW = Forward primer; RW = Reverse primer; Int. Span. = Intron spanning, i.e. Primers derived from different exons; Exon = both primers 
derived from the same exon. β 2-MG = β 2-microglobulin. UBC = Ubiquitin C. YWHAZ = tyrosine 3-monooxygenase tryptophan 5-monooxygenase 
activation protein, zeta polypeptide.BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
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generate a range of concentration from 10 to 1012 copies/
µl. We thus disposed of DNA and RNA ranges stemming
from the same sequence. In parallel, a range of cDNA was
also generated from the RNA standards. Ranges of RNA
standard were reverse transcribed and then amplified in
parallel to the cDNA and DNA ranges by real time PCR
under the same conditions (same mix, same final volume,
same PCR plate). The slope of the standard curves gener-
ated by these three ranges as well as the corresponding
efficiency are shown in Table 2. The data show that the RT-
PCR efficiencies from CyProQuant-PCR are lower than
the PCR efficiencies from cDNA or DNA ranges for the
three genes. Since the PCR efficiencies of the cDNA and
DNA ranges are similar for each gene, this discrepancy is
due to the RT efficiency, which is lower than 100% (from
75% for IFN-γ  to 98% for TNF-α ). In addition, data show
that RT efficiency displays intergenic variation with a
lower efficiency for IFN-γ  compared to the two other
cytokines (Table 2).
In order to show that these intergenic differences were not
due to interassay variation, we compared amplification
efficiencies of TNF-α , β 2-MG, MIF and UBC from i) a sin-
gle cellular RNA sample, ii) a pooled RNA sample con-
taining standard RNA for each of the targets and iii) a
pooled DNA sample corresponding to the cDNA obtained
from the pooled RNA sample containing standard RNA
for each of the targets. Results obtained are summarised in
Table 3 and show that RNA amplification efficiencies vary
from one gene to the other but are not affected by the
molecular context since they do not differ between the
single cellular RNA sample and the pooled RNA sample.
Moreover, since the amplification efficiencies of the
pooled DNA sample have been normalised to 100%, the
difference of amplification efficiency between the RNA
samples and the pooled DNA corresponds to differences
in RT efficiency.
Altogether, these data demonstrate that RT efficiency dis-
plays intergenic variations that are not due to interassay
differences.
Impact of RT efficiency variability on transcripts quantification 
reliability
RT efficiency has critical impact on transcript quantifica-
tion as shown in Table 4. Indeed, if we compare CyPro-
Quant-PCR or DNA standard based approach for
quantification of a known number of TNF-α , IL-1β  and
Table 2: Comparison between CyProQuant-PCR and DNA standard-based approaches Efficiencies (E) are deducted from the slopes 
(S) of the standard curves based on E = 100*(10-1/S - 1). The deducted RT efficiency from the CyProQuant-PCR is calculated by dividing 
the RT-PCR efficiency from the RNA range (ERT-PCR) by the PCR efficiency from the cDNA range (EPCR).
Target gene CyProQuant-PCR DNA standard-based PCR
RNA range cDNA range Deducted RT 
efficiency
DNA range
Slope ERT-PCR Slope EPCR Slope EPCR
TNF-α -3.610 89 -3.556 91 98 -3.503 93
IL-1β -3.479 94 -3.197 105 89 -3.067 112
IFN-γ -3.843 82 -3.116 109 75 -2.944 119
Table 3: Intergenic difference of RT efficiencies is not due to interassay variation. Serial 1:10 dilutions of a single cellular RNA sample, 
of a pooled RNA sample and of a pooled DNA sample were used to generate standard curves for different targets (TNF-α , β 2-MG, MIF 
and UBC). Slopes were indicative of amplification efficiencies, which were normalised to 100% for the pooled DNA sample for easier 
comparison to amplification efficiencies of the two other samples.
Single cellular RNA sample Pooled RNA sample Pooled DNA sample
TNF-α 95 95 100
β 2-MG 90 90 100
MIF 88 88 100
UBC 81 80 100BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
Page 6 of 14
(page number not for citation purposes)
IFN-γ  transcripts, results show that DNA standard based
approach underestimates of around two logs the number
of transcripts. Moreover, this underestimation varies
according to the transcript studied and the experiment.
CyProQuant-PCR is thus more precise and more reliable
than the classically used DNA-based approaches.
Taken together, these results support the use of RNA as
external standard for reliable and reproducible quantifica-
tion of transcripts.
RT-PCR efficiency is similar for sample and RNA standard
Since RT-PCR efficiency varies, absolute mRNA quantifi-
cation can only be reliably obtained if the external RNA
standard and the cellular RNA are retro-transcribed and
amplified with the same efficiency. This was secured by
comparing the standard curves obtained after amplifica-
tion of a range of 10X serial dilution of cellular RNA and
β 2-MG external RNA standard. The slopes obtained were
of -3,307 and -3,305 for the cellular RNA and for the exter-
nal RNA standard, respectively. This corresponds to effi-
ciencies of 100,6% and 100,7% respectively (data not
shown).
Endogenous standard, normalization and reliability of the technique
The choice of a stable expressed endogenous gene to be
used as an internal standard is a prerequisite for accurate
RT-PCR expression profiling. This has to be adapted to the
clinical situation and the tissue of origin of the samples.
Since our purpose was to establish a technique to be used
with peripheral blood leukocytes, we tested three genes
reported in stable amounts in leukocytes: the β 2-MG, the
UBC and the YWHAZ [17]. We compared the stability of
the amount of transcript under different conditions of
activation. Total cellular RNA was extracted on two
different days from the same two aliquots of PBMC stim-
ulated for 3 hours by LPS. Thus, reverse transcription was
realised on RNA extracted from the same number of cells.
The three endogenous gene transcripts were amplified by
CyProQuant-PCR in the same plate in duplicate using the
same PCR master mix. Table 5 shows the mean of the
results obtained for the two extractions. The data show
that β 2-MG transcripts are stable with less than 12% of
variation whereas UBC and YWHAZ transcript levels
showed up to 47% variability depending on the in vitro
conditions. Moreover, based on the approach recently
described by Pachot et al. [18], we assessed the inter-indi-
vidual variability of the β 2-MG basal level using whole
Table 4: RNA and DNA standard-based quantification of TNF-a, IL-1β  and IFN-γ  transcripts Fifty million copies of TNF-α , IL-1β  and 
IFN-γ  standard RNA were amplified in parallel of a range of RNA standard (CyProQuant-PCR) and DNA standard. Copy numbers 
were directly deduced from the cycle at threshold. *For TNF-α , the experiment was repeated at two days interval.
Target gene Actual copy number Calculated copy number
CyProQuant-PCR DNA standard approach
TNF-α *5  1 0 7 5.2 107 7.7 105
5 107 5.0 107 3.6 105
IL-1β 5 107 4.3 107 6.7 105
IFN-γ 5 107 5.5 107 7.8 105
Table 5: Expression stability of endogenous standard genes under non-normalised conditions After 3 hours of stimulation with LPS, 
PBMC from healthy donors were split in 2 identical aliquots and total cellular RNA was extracted at 2 days interval. The same volume 
of RNA was reverse transcribed and β 2-MG, UBC and YWHAZ transcripts were amplified by real time PCR using CyProQuant-PCR 
technique. Results show the mean values obtained for the 2 extractions in arbitrary units.
Stimulation conditions Molecules detected (arbitrary units)
T0 LPS 3 h
β 2-MG 1.24 107 1.48 107
(1.00 107 – 1.49 107) (1.17 107 – 1.79 107)
UBC 2.04 105 2.39 105
(0.62 105 – 3.46 105) (1.51 105 – 3.28 105)
YWHAZ 1.89 105 2.80 105
(0.78 105 – 3.01 105) (2.25 105 – 3.34 105)BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
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blood samples from 6 different healthy donors. All CT val-
ues were within 19 and 21,86 cycles, which corresponds
to a variation of less than 5 times in gene expression for
an overall RT-PCR reaction efficiency of 1,81 (slope = -
3,867). This is considered as acceptable for a reference
gene [18]. β 2-MG was thus chosen as an internal standard
gene for future experiments. The same conclusions were
drawn using PHA (phytohemagglutinin) as a stimulant
(data not shown). In addition, these data validate the reli-
ability and reproducibility of our RNA extraction
protocol.
Validation of the CyProQuant-PCR technique
Human TNF-a transcript quantification: comparison of CyProQuant-
PCR to TaqMan®
Since TaqMan® technology developed by Applied Biosys-
tems is considered as the "gold standard", we compared
CyProQuant-PCR to TaqMan® for the quantification of
TNF-α  transcripts in isolated monocytes stimulated for 6
hours with LPS. Total RNA was extracted from 106 cells
and 10X serial dilutions were prepared and reverse tran-
scribed. The resulting cDNA were amplified in duplicate
on the same plate in the same thermocycling conditions
using either the TaqMan® commercial kit (Applied Biosys-
tems) or CyProQuant-PCR primers with SYBR Green PCR
master mix (Applied Biosystems). Figure 2 shows the
curves obtained using the two techniques on the same
samples. This indicates that CyProQuant-PCR is as good
as TaqMan® in terms of sensitivity and even more efficient:
105% (slope -3,198) for CyProQuant-PCR versus 80 %
(slope -3,908) for TaqMan®.
Quantification of TNF-α  and MIF by CyProQuant-PCR and ELISA
To validate our approach, we measured the levels of TNF-
α  and MIF transcripts and secreted proteins by CyPro-
Quant-PCR and ELISA respectively. PBMC from healthy
individuals were stimulated by LPS or SAC for 3, 9 and 18
hours. Figure 3 shows an increase of TNF-α  transcripts
after 3 hours of stimulation that precedes protein secre-
tion. In contrast, MIF transcripts were constitutively
present at the steady state and LPS or SAC stimulation did
not significantly modify the level of transcripts although
it induces the release of substantial amounts of MIF pro-
teins. This is in agreement with reports showing that MIF
exists within cells under homeostasis both as a preformed
protein ready to be secreted and as a messenger RNA,
which can then be rapidly translated in the absence of
induced transcription [19].
Early cytokine profiling of PBMC from healthy donors stimulated with 
LPS or SAC
To validate the panel of primers designed for CyPro-
Quant-PCR, we assessed the early cytokine response as
well as the kinetics of expression for PBMC from two
healthy donors under stimulation with LPS or SAC. Figure
4 illustrates CyProQuant-PCR detection of IL-1β , IL-4, IL-
10, IL-12p40, IL-13, IL-15, IL-18, MIF, TGF-β 1 and TNF-α
transcripts for one donor. No significant increase in IL-15,
IL-18, MIF or TGF-β 1 transcripts was detected. Both stim-
ulants induce a similar kinetics of transcript accumulation
for IL-1β  and IL-10. In contrast, IL-4 and IL-13 transcripts
peaked very early (2 hours) under LPS stimulation but not
under SAC stimulation. IL-12p40 transcripts also
accumulated earlier under LPS stimulation compared to
SAC but was detected later on. The amount of TNF-α  tran-
script was sustained under SAC stimulation compared to
LPS. Detection of the corresponding proteins for TNF-α ,
IL-10 and IL-12p40 confirmed the mRNA profile
observed (data not shown). The amplitude of the
response differed somewhat between the two donors but
the kinetics obtained for each cytokine were similar (data
not shown).
Application: Use of CyProQuant-PCR to quantify TGF-β 1 transcripts 
in malaria patients
Before the application to clinical samples, the experimen-
tal reproducibility of CyProQuant-PCR was evaluated
using a range of TGF-β 1 and β 2-MG RNA standards. Inter-
experimental variability was assessed from eight inde-
pendent experiments. The coefficients of variation were
satisfactory whatever the starting copy number of RNA
standard, ranging from 0,39 to 1,07% and from 0,91 to
1,2% for TGF-β 1 and β 2-MG respectively (Table 6). TGF-
β 1 transcripts were then quantified after LPS stimulation
of PBMC from malaria patients and asymptomatic con-
trols. Figure 5 shows a significant difference in the amount
of TGF-β 1 transcripts between patients and asymptomatic
controls only after LPS stimulation (p = 0,036).
Discussion
In this paper we have described a new technique, CyPro-
Quant-PCR, for absolute quantitative profiling of human
cytokine mRNA using real time RT-PCR. Although real
time PCR is now becoming a popular technique, it still
requires improvement for proper quantification. All the
techniques for absolute quantification available so far use
a DNA standard curve assuming that RT efficiency is con-
stant and approaches 100% [12]. We show here that RT is
not 100% efficient, and more importantly, that its effi-
ciency changes from one gene to another and from one
experiment to another. We thus designed primers and
standard RNA to be used in such a way that all cytokine
mRNA of interest as well as three housekeeping genes
could be amplified using the same conditions
(thermocycling parameters and buffer). This technique is
rapid, reliable and reproducible. When compared to the
TaqMan®  commercial kit, which represents the "gold
standard", CyProQuant-PCR was as sensitive but less
expensive and more flexible. Indeed, for a given gene, the
design of the probe might be quite difficult and, with judi-BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
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Comparison to TaqMan® technology Figure 2
Comparison to TaqMan® technology. Total RNA was extracted from isolated monocytes stimulated for 6 hours by LPS, 
serial-diluted 1:10 and retro-transcribed to generate standard curves by plotting the CT against the concentration of this cellu-
lar RNA in arbitrary units. TNF-α  transcripts were amplified by real time PCR using either (A) the TaqMan® commercial kit 
and the TaqMan® universal PCR master mix or (B) our primers and the SYBR Green PCR master mix. Data represent the 
standard curves obtained for the two techniques, their slopes and the deducted efficiencies.
A. TaqMan®: slope = -3.908 / Efficiency = 80%
B. CyProQuant-PCR: slope = -3.198 / Efficiency = 105%
Dilution (arbitrary units)
Dilution (arbitrary units)BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
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cious selection of primer pairs, comparable sensitivity can
be achieved with the use of SYBR Green [20].
A major reason for not using an RNA standard curve is its
poor stability due to its sensitivity to RNase degradation.
In our hands, we did not find any detectable degradation
when keeping the standard in concentrated aliquots
(stock solution at 1000 µg/mL) in RNase-free water at
minus 80°C and avoiding freeze-thawing cycles. How-
ever, for a greater stability, we incorporated modified
dNTP, 2'-Fluoro-dCTP and 2'-Fluoro-dUTP, which have
been reported to decrease the sensitivity of the in vitro
transcribed RNA to specific RNases [21,22], and tested the
effect of this incorporation on the RT-PCR efficiency. We
did not find significant difference in the efficiencies
(100% for the non-modified IL-4 standard versus 104%
for the 2'-Fluoro-standard) (data not shown).
The methodology described here was easily and success-
fully applied to the quantification of several cytokine
genes. The quantification is reliable on 7 to 8 logs with a
sensitivity ranging from 1000 to 100 copies depending
the cytokine. It was first used to determine the magnitude
and the kinetics of early induction of cytokines mRNA
upon PBMC stimulation using bacterial derived materials.
This showed that CyProQuant-PCR is powerful enough to
detect early on modest cytokine induction such as IL-4.
Such a tool is useful to decipher the kinetics of cytokine
response involved in physiopathological pathways but
TNF and MIF transcription and secretion kinetics Figure 3
TNF and MIF transcription and secretion kinetics. PBMC from 2 donors were stimulated for 3, 9 or 18 hours (T3, T9 
and T18 respectively) with LPS or SAC. TNF-α  and MIF transcripts were quantified using CyProQuant-PCR and the corre-
sponding secreted proteins were measured by ELISA. Transcript numbers are normalised for one million copies of β 2-MG 
RNA relative to the level of transcripts in un-stimulated cells (fold increase). Secreted proteins are expressed as pg/mL for one 
million living cells.
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Early cytokine production kinetics by PBMC stimulated in vitro with LPS or SAC Figure 4
Early cytokine production kinetics by PBMC stimulated in vitro with LPS or SAC. Total cellular RNA was 
extracted from PBMC from 2 donors stimulated for 0.5, 1, 2, 3, 6 or 9 hours with LPS (blue bars) or SAC (red bars). Cytokine 
transcripts were quantified using CyProQuant-PCR. The results are shown for one donor and were expressed in mRNA copy 
numbers calculated relative to un-stimulated cells, after normalisation against β 2-MG (fold increase).
IL-1ß
0
10
20
0 , 5 12369
IL-4
0
50
100
0,5 1 2 3 6 9
IL-10
0
5
10
0 , 5 12369
IL-12p40
0
12500
25000
0,5 1 2 3 6 9
IL-13
0
200
400
0 , 5 12369
IL-15
0
5
10
0 , 5 12369
IL-18
0
5
10
0 , 5 12369
TGF-ß1
0
5
10
0 , 5 12369
TNF-α α α α
0
50
100
150
0,5 1 2 3 6 9
MIF
0
5
10
0 , 5 12369
Hours of stimulation
m
R
N
A
c
o
p
y
n
u
m
b
e
r
s
(
f
o
l
d
i
n
c
r
e
a
s
e
)BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
Page 11 of 14
(page number not for citation purposes)
also as a read-out to measure minor immune responses to
specific antigens [23].
We finally applied CyProQuant-PCR to measure the level
of TGF-β 1 transcripts in asymptomatic controls and
malaria patients after LPS stimulation. Interestingly, we
observed that cells from malaria patients have a
significant higher capacity to respond to LPS compared to
controls. The increased TGF-β 1 transcript accumulation
by patients' cells, suggests that an inadequate production
of TGF-β 1 might play a role in malaria pathogenesis as
already proposed [24]. Further work is needed to elabo-
rate on this finding. This first study provided the proof
that CyProQuant-PCR is readily applicable to small
clinical samples from paediatric cases. This opens the pos-
sibility to further quantify the cytokine imbalance associ-
ated with malaria pathogenesis and generate a disease
cytokine signature, a prerequisite for novel therapeutic
interventions targeting cytokine gene expression. Areas of
application include both infectious and non-infectious
diseases, as well as chronic inflammatory diseases such as
rheumatoid arthritis or sarcoidosis and acute diseases
such as sepsis or malaria. Beside its importance in patient
immuno-monitoring, cytokine profiling is also a major
tool to study specific immune response against antigens
TGF-β 1 transcripts quantification in malaria patients and asymptomatic controls Figure 5
TGF-β 1 transcripts quantification in malaria patients and asymptomatic controls TGF-β 1 transcripts were quanti-
fied without stimulation and after 22 hours of LPS stimulation of PBMC harvested from asymptomatic controls (n = 5) and 
from patients suffering from acute malaria (n = 20). Results are normalised for one million copies of β 2-microglobulin. Whisk-
ers indicate data range, boxes extend from the 25th to the 75th percentile and the horizontal lines show the median. Asterisk 
indicates significant higher value in malaria patients compared to asymptomatic controls (p = 0.036) in the capacity of response 
to LPS.
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for design and testing of immuno-modulatory drugs or
vaccines.
Conclusion
In conclusion, we provide here CyProQuant-PCR, a sim-
ple technique for genuine absolute quantification of
cytokine mRNA using SYBR Green® which is as sensitive as
the TaqMan®  technique. Because the parameters of
amplification are identical for all the cytokines developed,
CyProQuant-PCR is readily automatable notably for 384-
well plates and might allow multiple cytokine profiling of
samples of very limited size at a relatively high through-
put. CyProQuant-PCR opens the possibility to use
cytokine mRNA measurements in clinical studies not only
for an increased knowledge but also to help clinicians in
patients' stratification and treatment decision.
Methods
Healthy human PBMC: isolation and in vitro stimulation
Blood was collected from healthy donors at the French
Blood Bank. Peripheral blood mononuclear cells (PBMC)
were isolated by density separation over Ficoll Hypaque
and washed two times in RPMI 1640 (Gibco BRL, Invitro-
gen, Cergy Pontoise, France). Cells were re-suspended in
RPMI 1640 (Gibco BRL, Invitrogen, Cergy Pontoise,
France) supplemented with 2 mM glutamine (Gibco BRL,
Invitrogen, Cergy Pontoise, France) and 10% AB+ human
serum (French Blood Bank) at 2.106 cells/mL and either
used directly for RNA extraction or cultured in duplicate
with or without LPS (10 ng/mL, E. Coli O111: B7, Sigma,
L'Isle d'Abeau Chesnes, France) or SAC (0,0075%, Pan-
Sorbine Cells, Calbiochem, La Jolla, CA, USA). After incu-
bation, cells were washed with PBS and re-suspended in
RNA-PLUS (Q-Biogene, Illkirch, France) for RNA
isolation.
Malaria patients and asymptomatic controls
Twenty children admitted during the high malaria trans-
mission season of 2001 to the emergency room at the
Department of Child Health, Korle-Bu Teaching Hospital,
Ghana were included. Five asymptomatic controls
matched to patients for age, residence location and time
of sample collection were enrolled. The general inclusion
and exclusion criteria were as described by Kurtzhals et al.
[25]. Parents or guardians signed informed consent forms.
The study received ethical clearance from The Ethics and
Protocol Review Committee at the university of Ghana
Medical School and the Ministry of Health. Total cellular
RNA was extracted from PBMC recovered from 500 µL of
blood following supplier's instructions (RNA PLUS, Q-
Biogene, Illkirch, France) after 22 hours of incubation at
37°C, 5% CO2 with or without LPS (10 ng/mL, E. Coli
O111: B7, Sigma, L'Isle d'Abeau Chesnes, France).
RNA isolation
RNA was extracted following supplier's instructions, re-
suspended in 60 µL of RNase-free water (Ambion,
Huntingdon, UK) and quantified spectrophotometrically
at 260 nm.
Primers
Oligonucleotide primers were synthesized at Eurogentec
(Saraing, Belgium). To validate primers, a pool of cDNA
from healthy human PBMC stimulated for 6 and 12 hours
with LPS (10 ng/mL, E. Coli O111: B7, Sigma, L'Isle
d'Abeau Chesnes, France) and PHA-L (10 µg/mL, Sigma-
Aldrich, Lyon, France) was used. Analysis of the ampli-
cons was assessed by 4% agarose gel electrophoresis and
dissociation curve studies using Dissociation Curve Soft-
ware (Applied Biosystems, Foster City, CA, USA). PCR
products were cloned into pCR2.1 vector using Original
Table 6: Inter-experimental reproducibility of the quantification of a range of TGF-β 1 and β 2-MG RNA standards A set of TGF-β 1 and 
β 2-MG RNA standards ranging from 103 to 1010 copies was amplified by RT-PCR. Coefficients of inter-experimental variation were 
determined from eight different experiments and calculated for threshold cycles.
Absolute copy number Coefficients of inter-experimental variations (%)
TGF-β 1 β 2-MG
1.00E+03 1.04 1.20
1.00E+04 1.07 1.19
1.00E+05 0.94 1.13
1.00E+06 0.90 1.08
1.00E+07 0.79 0.95
1.00E+08 0.71 0.91
1.00E+09 0.54 0.93
1.00E+10 0.39 1.18
Average 0.80 1.07BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
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TA cloning kit (InVitrogen, Cergy Pontoise, France) and
sequenced (Genome Express, Meylan, France).
Construction of the external DNA and RNA standards
PCR products generated by each primer pairs were col-
umn-purified (Nucleospin, Macherey-Nagel, Hoerdt,
France) and quantified spectrophotometrically at 260 nm.
The molecular weight of the standard DNA was calculated
by N*487-[(N-1)*175] were N is the number of bases
composing the standard DNA. Stock solution of 1012 cop-
ies of standard DNA /3,85 µL were made in Tris-EDTA
buffer (Ambion, Huntingdon, UK), split in single-use
aliquots and stored at -80°C in safe-lock tubes. External
DNA standard range was made extemporaneously by 1:10
serial dilutions in water.
Gene specific primers were fused on their 5' end to the
sequence of the RNA polymerase T7 promoter to generate
modified primers. These primers were used to amplify a
gene specific PCR product flanked by transcription initia-
tion sites. Five hundred nanograms of this construct were
in vitro transcribed (MegaShortScript, Ambion, Hunting-
don, UK). The standard RNA generated was purified
(MegaClear, Ambion, Huntingdon, UK) and loaded on a
4% agarose gel for electrophoresis. The concentration of
the standard RNA was determined spectrophotometrically
at 260 nm. The molecular weight of the transcript was
calculated by N*500-[(N-1)*175] were N is the number
of bases composing the standard RNA. Stock solution of
1012 copies of standard RNA /3,85 µL were made in RNA
storage solution (Ambion, Huntingdon, UK), split in sin-
gle-use aliquots and stored at -80°C in safe-lock tubes.
External RNA standard range was made extemporane-
ously by 1:10 serial dilutions in water.
Reverse transcription
For CyProQuant-PCR assays, 100 ng of total cellular RNA
from PBMC and serial dilution of external RNA standard
were reverse transcribed simultaneously in a parallel pro-
cedure using Reverse Transcription TaqMan reagents
(Applied Biosystems, Foster City, CA, USA) on a Master-
Cycler Gradient (Eppendorf, Le Pecq, France). The final
volumes were set at 100 µL for the cellular RNA samples
and 50 µL for the external RNA standard range. The ther-
mocycling parameters were as follows: 25°C, 10 min.;
48°C, 60 min. and 95°C, 5 min. cDNA were immediately
used for PCR amplification.
Real-time RT-PCR and quantification of transcripts
Reverse-transcribed standard RNA and cellular RNA were
amplified simultaneously on the same PCR plate on an
ABI Prism 7700 (Applied Biosystems, Foster City, CA,
USA). An aliquot of 5 µL of the RT reaction was amplified
in duplicate in a final volume of 30 µL of SYBR Green PCR
Master mix (Applied Biosystems, Foster City, CA, USA).
Thermocycling conditions were 50°C for 2 min., 95°C for
10 min. and 40 cycles of [95°C/15 sec.; 60°C, 1 min]. The
sample target RNA copy numbers were calculated using
SDS 1.9 Software (Applied Biosystems, Foster City, CA,
USA). The baseline fluorescence was set manually to cor-
rect for differences in initial cDNA concentration and the
threshold was positioned at a fluorescence level that was
10 times higher than the background signal. Target mRNA
copy numbers in cellular samples were calculated based
on a standard curve generated by SDS 1.9 Software
(Applied Biosystems, Foster City, CA, USA) by plotting
cycles at threshold (CT) against the logarithmic values of
the starting RNA standard copy number.
ELISA tests
TNF-α  and MIF secreted proteins were quantified by sand-
wich ELISA following supplier's instructions (Bio-Source,
Clinisciences, Montrouge, France and R&D, Lille, France
respectively). Results are expressed as pg/mL for one mil-
lion living cells.
Statistical analysis
Tests for significance were done using Stata software (Stata
Corporation, College Station, Texas, 77845 USA) by
Kruskal-Wallis rank test.
Patent application
Results disclosed in this manuscript have been protected
in French patent application FR0408645.
Authors' contributions
PB developed the entire technique. IV did the in vitro stim-
ulation experiments. DJ gave technical assistance. SL
helped in RNA extraction of malaria samples. JCB intro-
duced PB to molecular biology techniques and provided
critical advices. BDA designed and conducted the study
that yielded the malaria samples. OMP revised the manu-
script and supported the work. CB conceived the strategy
and coordinated the study. PB and CB drafted the manu-
script. All authors read and approved the final
manuscript.
Acknowledgements
This work was supported by the European Commission program INCO-
DC (Grant n°IC18-CT-980370), by the WHO/TDR/MIM project 980037 
and by the program DVPI of the Pasteur Institute. Philippe Boeuf was sup-
ported by a PhD fellowship from the PAL-PLUS program (French Ministry 
of Technology, Research and National Education) and from CANAM 
(Caisse Nationale d'Assurance Maladie et Maternité des Travailleurs non 
Salariés des Professions non Agricoles).
References
1. Aggarwal BB, Puri RK, eds: Human cytokines: their role in Dis-
ease and Therapy. Cambridge, MA: Blackwell Science; 1995. 
2. Dinarello CA: Role of pro-inflammatory and anti-inflamma-
tory cytokines are mediators in the pathogenesis of septic
shock. Chest 1997, 112:321S-329S.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Immunology 2005, 6:5 http://www.biomedcentral.com/1471-2172/6/5
Page 14 of 14
(page number not for citation purposes)
3. Carson RT, Vignali TAA: Simultaneous quantitation of 15
cytokines using a multiplexed flow cytometric assay. J Immu-
nol Methods 1999, 227:41-52.
4. Gogos CA, Drosou E, Bassaris HP, Skoutelis A: Pro-versus anti-
inflammatory cytokine profile in patients with severe sepsis:
a marker for prognosis and future therapeutic options. J Infect
Dis 2000, 181:176-180.
5. Zegarska J, Paczek L, Pawlowska M, Podrzucki W, Rowinski W,
Malanowski P, Wszola M, Mroz A: Quantitative gene expression
of TGF-β 1, TNF-α , IL-1β  and IL-6 in the renal artery wall of
chronically rejected renal allografts.  Transplant Proc 2002,
34:3176-3179.
6. Salmeri FM, Sofo V, Ando FG, Vastola MB, Crosca S, Bitto A, Gaeta
M, Girbino G: Imbalance of serum cytokine network in sarcoid
patients: index of sarcoidosis relapse. Sarcoidosis Vasc Diffuse
Lung Dis 2003, 20:53-61.
7. Semnani RT, Liu AY, Sabzevari H, Kubofcik J, Zhou J, Gilden JK, Nut-
man TB: Brugia malayi microfilariae induce cell death in
human dendritic cells, inhibit their ability to make IL12 and
IL10 and reduce their capacity to activate CD4+ T cells. J
Immunol 2003, 171:1950-1960.
8. Zimmermann AK, Simon P, Seeburger J, Hoffmann J, Ziemer G,
Aebert H, Wendel HP: Cytokine gene expression in monocytes
of patients undergoing cardiopulmonary bypass surgery
evaluated by real-time PCR. J Cell Mol Med 2003, 7:146-156.
9. Overbergh L, Giulietti A, Valckx D, Decallonne B, Bouillon R, Mathieu
C: The use of real-time reverse transciptase PCR for the
quantification of cytokine gene expression. J Biomol Tech 2003,
14:33-43.
10. Rajeevan MS, Ranamukhaarachchi DG, Vernon SD, Unger ER: Use of
real-time quantitative PCR to validate the results of cDNA
array and differential display PCR technologies. Methods 2001,
25:443-451.
11. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY:
Distinct patterns of gene expression in the skin lesions of
atopic dermatitis and psoriasis: a gene microarrays analysis.
J Allergy Clin Immunol 2003, 112:1195-1202.
12. Ramos-Payan R, Medina-Aguilar M, Estrada-Parra S, Gonzalez-y-Mer-
chand JA, Favilla-Castillo L, Monroy-Ostria A, Estrada-Garcia CE:
Quantification of cytokine gene expression using an econom-
ical real-time PCR polymerase reaction method based on
SYBR® Green I. Scand J Immunol 2003, 57:439-445.
13. Radonic A, Thulke S, Mackay IM, La d O, Siegert W, Nitsche A:
Guideline to reference gene selection for quantitative real-
time PCR. Biochem Biophys Res Commun 2004, 313:856-862.
14. Bustin SA: Absolute quantification of mRNA using real-time
reverse transcription polymerase chain reaction assays. J Mol
Endocrinol 2000, 25:169-173.
15. Stordeur P, Poulin LF, Cracium L, Zhou L, Schandené L, de Lavareille
A, Goriely S, Goldman M: Cytokine mRNA quantification by
real-time PCR. J Immunol Methods 2002, 259:55-64.
16. Ginzinger DG: Gene quantification using real-time quantita-
tive PCR : An emerging technology hits the mainstream. Exp
Hematol 2002, 30:503-512.
17. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De
Paepe A, Speleman F: Accurate normalization of real time
quantitative RT-PCR data by geometric averaging of multi-
ple internal control genes. Genome Biol 2002, 3:34.I-34.II.
18. Pachot A, Blond J-L, Mougin B, Miossec P: Peptidylpropyl isomer-
ase B (PPIB): a suitable reference gene for mRNA quantifi-
cation in peripheral whole blood. J Biotechnol 2004, 114:121-124.
19. Calandra T, Froidevaux C, Martin C, Roger T: Macrophage migra-
tory inhibitory factor and host innate immune defenses
against bacterial sepsis. J Infect Dis 2003:S385-90.
20. Marino JH, Cook P, Miller KS: Accurate and statistically verified
quantification of relative mRNA abundances using SYBR
Green I and real-time RT-PCR.  J Immunol Methods 2003,
283:291-306.
21. Meis JE, Chen F: In vitro synthesis of 2'-fluoro-modified RNA
transcripts that are completely resistant to RNase A diges-
tion using the DuraScribe T7 transcription kit.  EPICENTRE
forum 2002, 9:10-11.
22. Heidenreich O, Eckstein F: Hammerhead ribozyme-mediated
clivage of the long terminal repeat RNA of human immuno-
deficiency virus type I. J Biol Chem 1992, 267:1904-1909.
23. Housseau F, Lindsey KR, Oberholtzer SD, Gonzales MI, Boutin P,
Moorthy AK, Shankara S, Roberts BL, Topalian SL: Quantitative
real-time RT-PCR as a method for monitoring T lymphocyte
reactivity to full-length tyrosinase protein in vaccinated
melanoma patients. J Immunol Methods 2002, 266:87-103.
24. Omer FM, Kurtzhals JAL, Riley EM: Maintaining the immunolog-
ical balance in parasitic infections : a role for TGF-β ? Parasitol
Today 2000, 16:18-23.
25. Kurtzhals JAL, Adabayeri V, Quarm-Goka B, Akanmori BD, Oliver-
Commey JO, Nkrumah FK, Behr C, Hviid L: Low plasma concen-
trations of interleukin 10 in severe malarial anaemia com-
pared to cerebral and uncomplicated malaria. Lancet 1998,
351:1768-1772.